Form 483

PLD Acquisitions LLC D/B/A Avema Pharma Solutions Form 483, 2014-04-23

FDA issued a Form 483 to PLD Acquisitions LLC D/B/A Avema Pharma Solutions on 2014-04-23 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

PLD Acquisitions LLC D/B/A Avema Pharma Solutions · Doral, United States · Issued April 23, 2014

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Apr 2014
21 CFR 111.12(c)

Personnel - education, training, experience

Cited by Ileana Barreto-Pettit, Stacey F Rivette

23 Apr 2014
21 CFR 111.25(c)

Procedures - equipment - cleaning, sanitizing

Cited by Ileana Barreto-Pettit, Stacey F Rivette

23 Apr 2014
21 CFR 111.320(a)

Examination, testing; appropriate

Cited by Ileana Barreto-Pettit, Stacey F Rivette

23 Apr 2014
21 CFR 111.365(a)

Conditions, controls -protect; microorganisms, contamination

Cited by Ileana Barreto-Pettit, Stacey F Rivette

23 Apr 2014
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Ileana Barreto-Pettit, Stacey F Rivette

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 111.12(c)Cited across public-safe Form 483 observations1x
21 CFR 111.25(c)Cited across public-safe Form 483 observations1x
21 CFR 111.320(a)Cited across public-safe Form 483 observations1x
21 CFR 111.365(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(5)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere